¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
¿Ã·¹Æ÷Æ® : ´ëÇз¹Æ÷Æ®, Á·º¸, ½ÇÇè°úÁ¦, ½Ç½ÀÀÏÁö, ±â¾÷ºÐ¼®, »ç¾÷°èȹ¼­, Çо÷°èȹ¼­, ÀÚ±â¼Ò°³¼­, ¸éÁ¢, ¹æ¼ÛÅë½Å´ëÇÐ, ½ÃÇè ÀÚ·á½Ç
·Î±×ÀΠ ȸ¿ø°¡ÀÔ

ÆÄÆ®³Ê½º

ÀÚ·áµî·Ï
 

Àå¹Ù±¸´Ï

´Ù½Ã¹Þ±â

ÄÚÀÎÃæÀü

¢¸
  • ½Å°æ°è¾à¹° °­ÀÇ   (1 ÆäÀÌÁö)
    1

  • ½Å°æ°è¾à¹° °­ÀÇ   (2 ÆäÀÌÁö)
    2

  • ½Å°æ°è¾à¹° °­ÀÇ   (3 ÆäÀÌÁö)
    3

  • ½Å°æ°è¾à¹° °­ÀÇ   (4 ÆäÀÌÁö)
    4

  • ½Å°æ°è¾à¹° °­ÀÇ   (5 ÆäÀÌÁö)
    5

  • ½Å°æ°è¾à¹° °­ÀÇ   (6 ÆäÀÌÁö)
    6

  • ½Å°æ°è¾à¹° °­ÀÇ   (7 ÆäÀÌÁö)
    7

  • ½Å°æ°è¾à¹° °­ÀÇ   (8 ÆäÀÌÁö)
    8

  • ½Å°æ°è¾à¹° °­ÀÇ   (9 ÆäÀÌÁö)
    9

  • ½Å°æ°è¾à¹° °­ÀÇ   (10 ÆäÀÌÁö)
    10

  • ½Å°æ°è¾à¹° °­ÀÇ   (11 ÆäÀÌÁö)
    11

  • ½Å°æ°è¾à¹° °­ÀÇ   (12 ÆäÀÌÁö)
    12

  • ½Å°æ°è¾à¹° °­ÀÇ   (13 ÆäÀÌÁö)
    13

  • ½Å°æ°è¾à¹° °­ÀÇ   (14 ÆäÀÌÁö)
    14

  • ½Å°æ°è¾à¹° °­ÀÇ   (15 ÆäÀÌÁö)
    15


  • º» ¹®¼­ÀÇ
    ¹Ì¸®º¸±â´Â
    15 Pg ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
¢º
Ŭ¸¯ : Å©°Ôº¸±â
  • ½Å°æ°è¾à¹° °­ÀÇ   (1 ÆäÀÌÁö)
    1

  • ½Å°æ°è¾à¹° °­ÀÇ   (2 ÆäÀÌÁö)
    2

  • ½Å°æ°è¾à¹° °­ÀÇ   (3 ÆäÀÌÁö)
    3

  • ½Å°æ°è¾à¹° °­ÀÇ   (4 ÆäÀÌÁö)
    4

  • ½Å°æ°è¾à¹° °­ÀÇ   (5 ÆäÀÌÁö)
    5

  • ½Å°æ°è¾à¹° °­ÀÇ   (6 ÆäÀÌÁö)
    6

  • ½Å°æ°è¾à¹° °­ÀÇ   (7 ÆäÀÌÁö)
    7

  • ½Å°æ°è¾à¹° °­ÀÇ   (8 ÆäÀÌÁö)
    8

  • ½Å°æ°è¾à¹° °­ÀÇ   (9 ÆäÀÌÁö)
    9

  • ½Å°æ°è¾à¹° °­ÀÇ   (10 ÆäÀÌÁö)
    10



  • º» ¹®¼­ÀÇ
    (Å« À̹ÌÁö)
    ¹Ì¸®º¸±â´Â
    10 Page ±îÁö¸¸
    °¡´ÉÇÕ´Ï´Ù.
  ´õºíŬ¸¯ : ´Ý±â
X ´Ý±â
Á¿ìÀ̵¿ : µå·¡±×

½Å°æ°è¾à¹° °­ÀÇ

ÀÎ ¼â
¹Ù·Î°¡±â
Áñ°Üã±â Űº¸µå¸¦ ´­·¯ÁÖ¼¼¿ä
( Ctrl + D )
¸µÅ©º¹»ç ¸µÅ©ÁÖ¼Ò°¡ º¹»ç µÇ¾ú½À´Ï´Ù.
¿øÇÏ´Â °÷¿¡ ºÙÇô³Ö±â Çϼ¼¿ä
( Ctrl + V )
¿ÜºÎ°øÀ¯
ÆÄÀÏ  ½Å°æ°è¾à¹° °­ÀÇ.hwp   [Size : 341 Kbyte ]
ºÐ·®   20 Page
°¡°Ý  1,000 ¿ø


īƮ
´Ù¿î¹Þ±â
īī¿À ID·Î
´Ù¿î ¹Þ±â
±¸±Û ID·Î
´Ù¿î ¹Þ±â
ÆäÀ̽ººÏ ID·Î
´Ù¿î ¹Þ±â
µÚ·Î

ÀÚ·á¼³¸í

½Å°æ°è¾à¹°¿¡ ´ëÇØ¼­ Á¤¸®ÇÏ¿´½À´Ï´Ù.
[ÀÇ¿¹]½Å°æ°è¾à¹°°­ÀÇ
¸ñÂ÷/Â÷·Ê
Introduction to Autonomic Pharmacology
Sympathomimetics
Adrenergic ¥â receptor blocking agents
º»¹®/³»¿ë

1. Epinephrine
1) Heart: positive inotrophic action, positive chronotrophic action, positive bathmotrophic action, positive dromotrophic action ⇨ C.O. Áõ°¡(limitation⇨°¨¼Ò), arrythmia
2) Ç÷°ü: contraction.
skeletal muscleÀÇ Ç÷°ü--therapeutic dose ⇨ relaxation
´ë·® ⇨ contration
3) Coronary blood flow : Áõ°¡ (¥á-adrenergic receptor, adnosine, aortic pressure, increased contractility, increase diastolic period)
4) Blood pressure: »ó½Â⇨Çϰ­⇨»ó½Â(reflex : vagus, atropine) ⇨⇨ Çϰ­(Á¤»óÇ÷¾ÐÀÌÇÏ)⇨ »ó½Â(Á¤»óÇ÷¾ÐÀ¸·Î, °í³óµµ--¥á, Àú³óµµ--¥â)
**Epinephrine reversal
**ÇÇÇÏÁÖ»ç, I.V.(slow) : Ç÷¾Ð»ó½ÂÀÌ ´Ê°Ô ¶Ç´Â ¾àÇÏ°Ô ³ªÅ¸³­´Ù.
5) Respiratory tract: bronchial smooth muscle relaxation, mucosal vessle contraction(removal of edema), inhibit mediator release from mast cell ⇨ treatment of athma, and allergy
6) Smooth muscle : GI smooth muscle relaxation, inhibit peristalsis(receptor, ¥â2,¥á receptor)




📝 Regist Info
I D : wdvc******
Date : 2014-04-14
FileNo : 16198741

Cart